To improve the discovery and advancement of innovative cancer therapeutics, the Case Comprehensive Cancer Center (Case CCC) is providing seed funding for the development of drug screening assays within the Small Molecule Drug Development Shared Resource (SMDD). This RFA is open to all Case CCC Members and applications will be accepted immediately on a rolling basis until all pilot award slots (5) are filled.
Applications are open immediately via InfoReady and will remain open until all Phase I projects are awarded.